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Abstract
Topoisomerases play a fundamental role in genome stability, DNA replication and repair. As a result, topoisomerases have
served as therapeutic targets of interest in Eukarya and Bacteria, two of the three domains of life. Since members of
Archaea, the third domain of life, have not been implicated in any diseased state to-date, there is a paucity of data on
archaeal topoisomerases. Here we report Methanosarcina acetivorans TopoIIIa (MacTopoIIIa) as the first biochemically
characterized mesophilic archaeal topoisomerase. Maximal activity for MacTopoIIIa was elicited at 30–35uC and 100 mM
NaCl. As little as 10 fmol of the enzyme initiated DNA relaxation, and NaCl concentrations above 250 mM inhibited this
activity. The present study also provides the first evidence that a type IA Topoisomerase has activity in the presence of all
divalent cations tested (Mg
2+,C a
2+,S r
2+,B a
2+,M n
2+,F e
2+,C o
2+,N i
2+,C u
2+,Z n
2+ and Cd
2+). Activity profiles were, however,
specific to each metal. Known type I (ssDNA and camptothecin) and type II (etoposide, novobiocin and nalidixic acid)
inhibitors with different mechanisms of action were used to demonstrate that MacTopoIIIa is a type IA topoisomerase.
Alignment of MacTopoIIIa with characterized topoisomerases identified Y317 as the putative catalytic residue, and a Y317F
mutation ablated DNA relaxation activity, demonstrating that Y317 is essential for catalysis. As the role of Domain V (C-
terminal domain) is unclear, MacTopoIIIa was aligned with the canonical E. coli TopoI 67 kDa fragment in order to construct
an N-terminal (1–586) and a C-terminal (587–752) fragment for analysis. Activity could neither be elicited from the fragments
individually nor reconstituted from a mixture of the fragments, suggesting that native folding is impaired when the two
fragments are expressed separately. Evidence that each of the split domains plays a role in Zn
2+ binding of the enzyme is
also provided.
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Introduction
Topoisomerases manage DNA supercoiling and are classified
according to the mechanism of action employed [1–4]. In general,
topoisomerases form a phosphotyrosine intermediate while
cleaving one strand (type I or odd-numbered) or two strands (type
II or even-numbered) of DNA. Before the initial transesterification
is reversed and a ligated DNA backbone regenerated, type I and II
enzymes change the DNA linking number (Lk) by 1 and 2,
respectively. Type I topoisomerases are ascribed further distinction
based on the polarity of the covalent intermediate formed. Type
IA (like Type II) forms a 59-phosphotyrosine adduct while type IB
forms 39-phosphotyrosine covalent adduct. Thus, the structure
and mechanism of each class are distinct.
The characterization of the first topoisomerase E. coli TopoI
(EcoTopoI), originally titled v protein, was an earnest exploration
into a field that has grown to be of burgeoning biological
importance [5]. Since then, topoisomerases have been demon-
strated to be vital components of the cellular machinery in a wide
array of processes that are essential for life, such as DNA
replication, DNA repair and chromosome segregation [6–8].
While these molecular machines have been identified in every
genome sequenced to date, irrespective of domain, eukaryotic and
bacterial topoisomerases have received greater scrutiny given their
role in diseased states such as Cancer and infections [9,10].
Interestingly, studies from bacteria and both lower and higher
eukaryotes have demonstrated that ablation of TopoIII (a
subfamily of type IA) activity in vivo without some compensatory
mechanism leads to genomic instability and/or abnormal growth
[11–16]. In spite of this direct evidence that TopoIII is vital for
normal development, the majority of archaeal studies have focused
on the non-essential Reverse Gyrase (a subfamily of type IA) given
its unique phylogenetic distribution in thermophiles and hy-
perthermophiles [17–20]. Furthermore, the only data published
on archaeal TopoIII are from hyperthermophilic organisms of the
archaeal subdomain Crenarchaeota [21–23].
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ofeconomically importantorganisms,includingboththe mesophilic
and hyperthermophilic methane-producing organisms. The meth-
ane-producing genus Methanosarcina is known to harness all known
substrates (including acetate, H2 and CO2, formate, methylamine
and methanol) to produce methane, a greenhouse gas [24]. Recent
reports also demonstrate that methanogens may be important in
human health, especially from the nutritional standpoint [25,26].
With the largest sequenced archaeal genome, Methanosarcina
acetivorans C2A provides a fertile ground for studies on archaeal
DNA metabolism. This organism has four putative topoisomerases
(six genes) tentatively named MacTopoIIIa [NP_617416], MacTo-
poIIIb [NP_616715], MacTopoVIA [NP_616519, NP_616520],
MacTopoVIB [NP_616517, NP_616516] [24]. Based on sequence
homology, MacTopoIIIa is classified as a type IA topoisomerase III
protein. In the present report, we characterize MacTopoIIIa, as the
first mesophilic archaeal TopoIII studied. The attributes shared
with orthologs from the other domains and those potentially specific
to Archaea are discussed.
Results
Expression and purification of MacTopoIIIa
In order to characterize MacTopoIIIa, the encoding gene was
amplified, cloned, expressed, and purified from E. coli cells as a
fusion protein with an N-terminal hexa-Histidine (6-His) tag.
Purification of the recombinant protein was achieved through
affinity chromatography, ion-exchange chromatography and size-
exclusion chromatography. Based on the polypeptide sequence,
the recombinant protein has an estimated molecular mass of
,86 kDa. As expected, the highly purified MacTopoIIIa
migrated between the 66 and 116 kDa molecular mass markers
via a 12% sodium dodecyl sulfate-polyacrylamide gel electropho-
resis (SDS-PAGE) according to the method of Laemmli (Fig. 1A,
lane 2) [27].
Catalytic properties of MacTopoIIIa
The putative topoisomerase was tested for the ability to relax
negatively supercoiled pUC18 (300 ng). As little as 10 fmol of
enzyme initiated relaxation upon addition to the reaction mixture
(Fig. 2A). Whereas 200 fmol of enzyme showed modest activity, 5
pmol of enzyme elicited maximal activity under standard assay
conditions. Analysis of aliquots of samples collected from the last
step (gel filtration column) demonstrated similar activities in all
fractions.
Maximal relaxation activity was observed around 30uC, and at
temperatures of 50uC and above, no relaxation was observed
(Fig. 2B). M. acetivorans C2A is an anaerobic mesophile that grows
optimally at 35–40uC. Therefore, the optimal temperature for
activity of MacTopoIIIa falls within the expected range of activity
[28]. Both Na+ and Mg2+ are required for growth of this
archaeon, and the optimal concentration of NaCl required was
200 mM. In the present study, at NaCl concentrations of 400 mM
or higher, the activity of MacTopoIIIa was almost not observable
(Fig. 2C). A similar observation was made for the effect of KCl
concentration on MacTopoIIIa activity. Initiation of activity by
the enzyme was observable as early as 15 seconds after addition of
MacTopoIIIa to the reaction mixture, and maximal activity was
observed within 5 min (Fig. 2D).
The effects of different divalent cations on MacTopoIIIa
activity
Topoisomerase activity was assessed as a function of divalent
cation concentration in a semi-logarithmic range of concentrations
from 50 mM to 10 mM (Fig. 3). We observed that each divalent
cation elicited a unique activity profile. As in previous studies on
topoisomerases, Mg
2+ was able to elicit maximal activity at
concentrations greater than or equal to 1 mM. Ca
2+ was the only
other cation that maintained a profile comparable to Mg
2+, with
concentrations greater than 1 mM showing near maximal
relaxation. In fact, relaxation activity of MacTopoIIIa at
concentrations above 1 mM appeared to be higher for Ca
2+
compared with Mg
2+.B a
2+ and Sr
2+ profiles were similar, but
were not able to relax the supercoiled substrate as effectively as
Mg
2+ and Ca
2+. The ability of these Group II alkaline metals to
elicit DNA relaxation activity at low cation concentration was,
therefore, as follows: Mg
2+ . Ca
2+ .. Ba
2+ . Sr
2+.
In the presence of Zn2+, activity was observed in a narrow
window of 100 mM. Zn2+ concentrations of 50 mM or less and
500 mM or more elicited no activity even when the reaction was
performed in a 1:1 enzyme:DNA molar ratio (data not shown). To
a lesser extent, Cd2+ was also able to elicit activity within a similar
narrow range. Relaxation activity was observed at 0.1 mM and
0.5 mM concentrations of Co2+, and at a concentration of 1 mM
or higher, either no activity was detectable or divalent cation-
catalyzed DNA degradation was observed. Fe2+ required a
concentration of 1 mM or higher for activity. However, DNA
degradation was also significant at concentrations above 1 mM.
These results are consistent with metal catalyzed DNA degrada-
tion seen with certain transition metals that are capable of
promoting the Haber-Weiss reaction [29,30]. Relaxation activity
in the presence of Mn2+ or Ni2+ or Cu2+ was also elicited under a
narrow range (100 mM – 1 mM).
Classification of MacTopoIIIa
To determine the class of MacTopoIIIa in the topoisomerase
family, its response to known topoisomerase inhibitors, with
different mechanisms of action, was investigated. Table 1 shows a
summary of the inhibitors tested. Ethidium bromide (EtBr) and
M13 ssDNA inhibited activity. The type I prokaryotic inhibitor
spermidine and the type I eukaryotic inhibitor camptothecin were
unable to inhibit the activity of MacTopoIIIa. Furthermore, the
type II inhibitors (etoposide, nalidixic acid and novobiocin) also
had no effect on the relaxation activity of MacTopoIIIa.
Relaxation activity was, however, inhibited by high concentrations
of KCl and NaCl (.400 mM). Based also on preliminary
analytical gel filtration experiments, MacTopoIIIa was estimated
to exist as a monomer in solution, which is consistent with the
oligomerization state of type 1A topoisomerases [3].
Catalytic Tyrosine of MacTopoIIIa is Y317
A sequence alignment using Sulfolobus solfataricus topoisomerase
III (SsoTopoIII) and the entire archaeal TopoIII subfamily II (of
which MacTopoIIIa is a member) was created to provide a hint at
the potential catalytic tyrosine (Fig. 1C), because SsoTopoIII is the
only archaeal TopoIII with a characterized active site tyrosine
[9,22]. The alignment suggested Tyr317 as the potential active site
residue of interest. Site-directed mutagenesis was used to create a
Y317F mutant. Size exclusion chromatography of MacTopoIIIa
Y317F yielded similar elution volume to that of the wild-type
protein, suggesting that the mutant also exists as a monomer in
solution (data not shown). The purified wild-type and mutant
proteins (Fig. 1A, lanes 2 and 3) were subjected to circular
dichroism scan to determine whether the mutation grossly
impacted the structure of MacTopoIIIa Y317F (Fig. 1C). No
gross differences between the structures could be discerned,
suggesting that the secondary structures of both enzymes are
comparable, outside of the point mutation. By subjecting the
Biochemical Characterization of MacTopoIIIa
PLoS ONE | www.plosone.org 2 October 2011 | Volume 6 | Issue 10 | e26903Figure 1. Purification and domain analysis of MacTopoIIIa. (A) SDS-PAGE of the purified recombinant proteins. Samples were loaded as
follows: 1, Protein molecular mass markers (Fermentas); 2, MacTopoIIIa wild-type; 3, MacTopoIIIa Y317F; 4, MacTopoIIIa N1-586; 5, MacTopoIIIa C587–
752. (B) Schematic representation of MacTopoIIIa wild-type, mutant (MacTopoIIIaY317F) and truncation (MacTopoIIIa C587–752 and MacTopoIIIa N1-
586) proteins, showing the five canonical domains with Domains I-IV distinguished from the C-terminal Domain V. The red asterisk indicates location
of the Y317F mutation. The domains are not drawn to scale. (C) Alignment of the active site of Archaeal TopoIII SubFamily II Topoisomerases with
Sulfolobus solfataricus P2 TopoIII. MacTopoIIIa, Methanosarcina acetivorans C2A TopoIIIa [NP_617416]; MmaTopoI, Methanosarcina mazei TopoI
[AAM32772]; MbaTopoI, Methanosarcina barkeri str. Fusaro TopoI [YP_305910]; MbuTopoI, Methanococcoides burtonii DSM 6242 TopoI [ABE51114];
MthTopoIII, Methanosaeta thermophila PT TopoIII [EAR48366]; HalTopoI, Halobacterium sp. NRC-1 TopoI [NP_444190]; AfuTopoIII, Archaeoglobus
fulgidus DSM 4304 TopoIII [AAB89443]; MhuTopoIII, Methanospirillum hungatei JF-1 TopoIII [ABD40761]; RxyTopoI, Rubrobacter xylanophilus DSM 9941
TopoI [ABG04911]; PtoTopoI, Picrophilus torridus DSM 9790 TopoI [YP_023525]; TvoTopoI, Thermoplasma volcanium GSS1 TopoI [NP_110538];
SsoTopoIII, Sulfolobus solfataricus P2 TopoIII [NP_342400]. The GenBank accession numbers are in brackets. The conserved and similar amino acids are
shaded black and gray, respectively. The putative catalytic residue is shaded red. (D) Circular Dichroism (CD) spectra of purified MacTopoIIIa wild-type
and the Y317F mutant. Triplicate data sets were collected from samples at a concentration of 0.5 mg/ml in a buffer containing 50 mM Tris-HCl pH 7.5,
200 mM NaCl, 2 mM DTT. All data sets were normalized against baseline readings from buffer containing no protein.
doi:10.1371/journal.pone.0026903.g001
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that MacTopoIIIa Y317F was unable to relax the negatively
supercoiled substrate under the same conditions where the wild-
type protein demonstrated activity (Fig. 4A). The products seen in
Lane 5 are likely to be due to iron catalyzed DNA degradation via
the Haber-Weiss reaction (refer to Fig. 3, last lane under Fe2+).
Truncation mutants
Two truncations of MacTopoIIIa were constructed based on
sequence alignment with the 67 kDa fragment of EcoTopoI [31].
Based on this sequence alignment, the MacTopoIIIa sequence was
spliced at a position between two small aliphatic residues (A586
and I587) where no secondary structure was apparent based on
secondary structure prediction (PredictProtein: http://www.
predictprotein.org/). We constructed two fragments, N1-586 and
C587–752, containing the N-terminal 586 amino acid residues
and the C-terminal 166 amino acid residues, respectively. Both
truncations were cloned, overexpressed and highly purified.
Neither the N1-586 nor the C587–752 fragment was able to relax
the same substrate as the wild-type under standard assay
conditions (Fig. 4B and 4C). To determine whether relaxation
activity could be reconstituted by mixing the two fragments, they
were incubated briefly prior to addition to the reaction mixture at
varying ratios (50:1, 5:1 and 1:1). However, no relaxation activity
was observed (Fig. 4C). To determine whether higher concentra-
tions of the two fragments will elicit topoisomerase activity, we
examined concentrations up to five times the maximum
concentration used for the wild-type protein; however, no
Figure 2. Characterization of activity based on protein concentration, salt and time. (A) Concentration dependent relaxation of negatively
supercoiled pUC18 DNA by MacTopoIIIa wild-type. Standard reaction mixtures with 90 mM NaCl were incubated with 0.3 mg of pUC18 for 30 min at
37uC with 10 mM MgCl2. From left to right, lanes contain increasing amounts of enzyme as labeled. fI, form I; fII, form II. (B) Temperature dependent
relaxation of negatively supercoiled pUC18 DNA by MacTopoIIIa wild-type. Standard reaction mixtures containing 5 pmol of enzyme were incubated
with 0.3 mg of pUC18 for 30 min with 10 mM MgCl2. Lane C contains no divalent cation and was incubated at 37uC. The remaining lanes were
incubated for 5 min at the indicated temperature prior to the addition of enzyme. (C) Salt dependent relaxation of negatively supercoiled pUC18
DNA by MacTopoIIIa wild-type. Standard reaction mixtures containing 5 pmol of enzyme were incubated with 0.3 mg of pUC18 for 30 min at 37uC
with 10 mM MgCl2. Lane C contains 90 mM NaCl. From left to right, remaining lanes contain increasing amounts of NaCl or KCl as labeled. (D) Time
dependent relaxation of negatively supercoiled pUC18 DNA by MacTopoIIIa wild-type. Standard reaction mixtures of enzyme were incubated with
pUC18 at 37uC with 10 mM MgCl2. Lane C contains no divalent cation. Time points of the reaction were taken as indicated.
doi:10.1371/journal.pone.0026903.g002
Biochemical Characterization of MacTopoIIIa
PLoS ONE | www.plosone.org 4 October 2011 | Volume 6 | Issue 10 | e26903Figure 3. Cation-dependent DNA relaxation activity profiles of MacTopoIIIa wild-type. Relaxation of negatively supercoiled pUC18 DNA
by MacTopoIIIa wild-type. Standard reaction mixtures with 90 mM NaCl containing 5 pmol of enzyme were incubated with 0.3 mg of pUC18 for
30 min at 37uC with the corresponding divalent cation. Lanes 1–8 contain increasing amounts of the indicated divalent cation: Lane 1, 0 mM; Lane 2,
50 mM; Lane 3, 100 mM; Lane 4, 500 mM; Lane 5, 1 mM; Lane 6, 2.5 mM; Lane 7, 5 mM; Lane 8, 10 mM. fI, form I; fII, form II.
doi:10.1371/journal.pone.0026903.g003
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polypeptides or their mixture (Fig. S1). The polypeptides,
especially the C587-752 polypeptide, demonstrated DNA binding
activity at high concentrations. Further experiments will be
designed to characterize this property of the split MacTopoIIIa.
Zinc Content Measurements
In an effort to assess the Zn
2+ binding ability of this enzyme,
samples of wild-type and the two truncation mutants were
subjected to ICP-MS analysis. The wild-type enzyme was found
to contain 1.2960.01 mol of Zn
2+. The MacTopoIIIa N1-586
truncation was found to contain 0.6260.02 mol, and the C587–
752 truncation mutant was found to contain 0.4960.01 mol of
Zn
2+ (Fig. 5).
Discussion
MacTopoIIIa is promiscuous
A fundamental property of type IA topoisomerases is the
absolute requirement of Mg
2+ for the large conformational change
required during DNA relaxation, but other divalent cations can
substitute [5,32]. Recent publications have proposed a two metal
mechanism for type IA and type II topoisomerases wherein one
may bind acidic residues within the TOPRIM motif causing the
necessary large conformational changes while the other may play a
transient role in stabilizing the transition state in preparation for
Table 1. Summary of inhibition assays conducted with
MacTopoIIIa wild-type.
Chemical Inhibition
Ethidium Bromide Yes
M13 ssDNA Yes
Spermidine No
Camptothecin No
Etoposide No
Nalidixic acid No
Novobiocin No
High [KCl] Yes
High [NaCl] Yes
Three independent trials were conducted to determine the ability of different
agents to inhibit DNA relaxation activity at increasing concentrations.
doi:10.1371/journal.pone.0026903.t001
Figure 4. Mutant and truncation DNA relaxation assays. (A) Standard reaction mixtures with 90 mM NaCl were incubated in the presence of 5
pmol of MacTopoIIIa Y317F with 0.3 mg of pUC18 for 30 min at 37uC unless stated otherwise. Lane PC contains 10 mM MgCl2 and 5 pmol of wild-type
enzyme only. Lane NC contains MacTopoIIIa Y317F only. Lane 1, 500 mM CoCl2; Lane 2, 100 mM CuCl2; Lane 3, 2 mM FeCl2; Lane 4, 10 mM MgCl2; Lane
5, 50 mM MnCl2; Lane 6, 500 mM NiCl2; Lane 7, 100 mM ZnCl2. fI, form I; fII, form II. (B) Relaxation of negatively supercoiled pUC18 DNA by MacTopoIIIa
N1-586. Standard reaction mixtures with 90 mM NaCl containing 5 pmol of enzyme were incubated with 0.3 mg of pUC18 for 30 min at 37uC. Lane 1
contains 10 mM MgCl2 and 5 pmol of MacTopoIIIa wild-type only. Lanes 2–9 contain increasing amounts of MgCl2: Lane 2, 0 mM; Lane 3, 50 mM; Lane
4, 100 mM; Lane 5, 500 mM; Lane 6, 1 mM; Lane 7, 2.5 mM; Lane 8, 5 mM; Lane 9, 10 mM. fI, form I; fII, form II. (C) Relaxation of negatively supercoiled
pUC18 DNA by MacTopoIIIa C587–752. Standard reaction mixtures with 90 mM NaCl containing 5 pmol of enzyme were incubated with 0.3 mgo f
pUC18 for 30 min at 37uC. Lane 1 contains 10 mM MgCl2 and 5 pmol of MacTopoIIIa wild-type only. Lanes 2–9 contain increasing amounts of MgCl2:
Lane 2, 0 mM; Lane 3, 50 mM; Lane 4, 100 mM; Lane 5, 500 mM; Lane 6, 1 mM; Lane 7, 2.5 mM; Lane 8, 5 mM; Lane 9, 10 mM. Lanes 10–14 contain
varying ratios of MacTopoIIIa C587–752 to MacTopoIIIa N1-586 ranging from 50:1, to 5:1 to 1:1 to 1:5 to 1:50, respectively. fI, form I; fII, form II.
doi:10.1371/journal.pone.0026903.g004
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measurements on E. coli TopoI (EcoTopoI) reveal that one Mg
2+
plays a role influencing the overall structure of the enzyme, while a
second Mg
2+ is required to achieve full catalytic activity [35].
Mutation of three acidic residues of EcoTopoI within the
TOPRIM domain only partially inhibited activity [36]. But even
when crystals were soaked in MgCl2,n oM g
2+ was detected in the
crystal structures of EcoTopoIII whether the wild-type was
covalently linked or whether the wild-type or mutant were primed
for attack at a scissile bond of ssDNA in a manner akin to S.
cerevisiae TopoII (SceTopoII) [37,38]. The data in total suggests
that two transient divalent cations are required for maximal
activity with one divalent cation binding in order to prime the
enzymatic structure for large conformational changes while the
second cation primes the phosphate linkage of interest for attack
before immediate removal from the active site.
And while the role of Mg
2+ is usually well examined, it is
commonplace for other divalent cations to receive less scrutiny
(Table 2). As one example, EcoTopoI DNA relaxation activity was
investigated in the presence of 0–10 mM Mg
2+ while Ca
2+ ,C o
2+,
Mn
2+ and Zn
2+ were investigated at 2 mM only [39]. In another
study, while the activity of human topoisomerase IIIa (hTopoIIIa)
was again tested in the presence of a range of MgCl2
concentrations, hTopoIIIa was deemed inactive in the presence
of other divalent cations based on one concentration (5 mM) [40].
We demonstrate for the first time that MacTopoIIIa is
promiscuous with regard to divalent cation (Ba
2+,C a
2+,C d
2+,
Co
2+,C u
2+,F e
2+,M g
2+,M n
2+,N i
2+,Z n
2+) and that each elicits a
unique activity profile. Unlike results with other topoisomerases,
we observe DNA relaxation activity in the presence of Zn
2+ albeit
under a narrow range [22,32]. These results are not plasmid-
specific as confirmed in the presence of 300 ng of either pUC18 or
pGEM-T (data not shown). While further studies are needed to
determine if all divalent cations may substitute in the mechanism
for all topoisomerases, our data clearly demonstrates that there is a
need to assess bivalent metal ion profiles and not simply examine
activity at a singular concentration. As a result, it is possible that
different divalent cations not previously reported to elicit activity
for any given topoisomerase indeed do elicit activity, although it
may be under a narrow range of concentrations. It also remains to
be seen whether these divalent cation profiles can act as a tool to
distinguish topoisomerases or whether this activity is specific to
Archaea or to this particular archaeon in the present study.
MacTopoIIIa is a type IA topoisomerase
Nalidixic acid, etoposide and novobiocin are specific inhibitors
of type II topoisomerases with different mechanisms of action [10].
Camptothecin is a known eukaryotic type I inhibitor that stabilizes
the binary protein-DNA complex intermediate thereby impeding
DNA relaxation [41]. None of these inhibitors were able to inhibit
the DNA relaxation activity of MacTopoIIIa. Ethidium bromide
induces positive supercoiling [42]. Type IA topoisomerases have a
preference for ssDNA and preferentially relax negatively super-
coiled DNA. Ethidium bromide and M13 ssDNA were each able
to inhibit activity. Thus, the sequence homology in combination
with the results from the inhibitor studies clearly demonstrates that
MacTopoIIIa is a type IA topoisomerase.
Figure 5. ICP-MS analysis of MacTopoIIIa wild-type and its
truncations. Purified recombinant MacTopoIIIa wild-type and trunca-
tion (MacTopoIIIaN1-586 and MacTopoIIIaC587–752) proteins were
submitted for zinc content analysis. The error bars represent standard
deviations for two independent measurements.
doi:10.1371/journal.pone.0026903.g005
Table 2. Summary of divalent cation studies.
Enzyme Mg
2+ Ca
2+ Sr
2+ Ba
2+ Mn
2+ Fe
2+ Fe
3+ Fe
4+ Co
2+ Ni
2+ Cu
2+ Zn
2+ Cd
2+ Ref
MacTopoIIIa YY M M YY - - Y M Y M M T h i s p a p e r
DmeTopoIIIb Y Y --Y ---N -N
S N
S - [53]
EcoTopoI Y Y
D --N
D ---L
D --L
D - [32]
FisTopoI Y N
D --N
D -----N
D -N
D [45]
HsaTopoIIIa Y ---N ---N N N N
S - [40]
M e t T o p I Y M - - Y YYY- - YN- [49]
NtaTopoI Y Y
D --M
D --- -N
D N
D - [54]
RcaTopoI Y Y - - Y -----N N -[55]
SauTopoI Y Y - - Y -----N N -[46]
S s o T o p o I I I Y M --N ---N NNN- [22]
A literature review was conducted on previously published studies where divalent cations other than Mg
2+ were utilized in type IA topoisomerase DNA relaxation
assays. The findings are summarized herein. Methanosarcina acetivorans C2A, Mac; Drosophila melanogaster, Dme; Escherichia coli, Eco; Fervidobacterium islandicum, Fis;
Homo sapiens, Hsa; Methylophaga sp. strain 3, Met; Nicotiana tabacum, Nta; Rhodobacter capsulatus, Rca; Staphylococcus aureus, Sau; Sulfolobus solfataricus, Sso;
D, data
not shown;
S,M
2+SO4 used in place of M
2+Cl2; Y, high activity; M, moderate activity; L, low activity; N, no activity.
doi:10.1371/journal.pone.0026903.t002
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to 100 mM. Spermidine was initially posited as a prokaryotic
polyamine topoisomerase inhibitor given its inhibitory effect on
both EcoTopoI and EcoTopoIII at physiological concentrations
[43,44]. However, the data actually suggests that it is a case by
case scenario within the domain Bacteria and the only archaeal
TopoIII tested to-date, SsoTopoIII, demonstrated no susceptibility
[22,45–49]. The data reveal that there is no definite trend for
polyamine susceptibility amongst bacterial type IA topoisomerases
and no demonstrated effect to-date in the domain Archaea.
Catalytic tyrosine is located at Y317
We assayed the Y317F mutant of MacTopoIIIa for activity
under conditions that were demonstrated to elicit relaxation
activity for wild-type. After analyzing the CD spectra of
MacTopoIIIa Y317F to ensure that there were no gross structural
differences compared to the wild-type, we demonstrated that
MacTopoIIIa Y317F was inactive under conditions where wild-
type had activity. This result confirmed our prediction that Tyr317
is indeed essential in the mechanism of DNA relaxation by
MacTopoIIIa.
N-terminal Zn
2+-binding activity
An open question about TopoI and TopoIII is the role that the
C-terminal (Domain V) plays in the context of Zn
2+-binding.
While lacking the C-terminal (Domain V), the EcoTopoI fragment
(Domains I–IV) retained the ability to cleave oligonucleotides, but
was not able to relax negatively supercoiled DNA [31]. With three
Zn
2+-binding sites in Domain V (the domain absent in the original
crystal structure), methyl methanethiosulfonate (MMTS)-treated
EcoTopoI abolished Zn
2+-binding and rendered the enzyme
incapable of catalyzing DNA relaxation [32]. Meanwhile, a double
mutant (Cys559A/Cys561A) or truncation that abolished Zn
2+-
binding in Thermotoga maritima TopoI (TmTopoI) only minimally
affected DNA relaxation activity [4]. No TopoI crystal structures
have been identified with Zn
2+ positioned even when it was
detected in the mother crystal liquor [50]. The story is further
confounded by the fact that there are several bacterial type IA
topoisomerases that contain no homologous Zn
2+-binding motif or
Zn
2+-binding ability [37,48,51]. A reasonable conclusion from the
current data available is that type IA topoisomerase Zn
2+-binding
motifs, when present in a given bacterial organism, play a
structural role that may or may not be essential for DNA
relaxation activity.
Given that MacTopoIIIa contains a C-terminal Cys-X2-Cys-
X17-Cys-X5-Cys motif and that there have not been any studies to
date examining the role of Zn
2+-binding in archaeal TopoIII, we
set out to determine whether MacTopoIIIa contains Zn
2+ in order
to delineate any potential differences with the well-characterized
bacterial topoisomerases. The results demonstrated that MacTo-
poIIIa binds to approximately one mole of Zn
2+ per mole of
protein. We then constructed, expressed and purified N-terminal
and C-terminal fragments to assess the Zn
2+-binding ability of
each segment. To our surprise, both the C-terminal fragment and
the N-terminal fragment demonstrated the ability to chelate
approximately a half mole of Zn
2+. To our knowledge, this is the
first report of an N-terminal fragment of a TopoIII or TopoI
having this ability to coordinate Zn
2+. It is likely that residues in
the two fragments coordinate Zn
2+ in the wild-type. Mutational
studies are currently underway to investigate the Zn
2+-binding role
that any of the eight His residues in the N-terminal and eleven
Cys/His residues in the C-terminal may play.
In this report, MacTopoIIIa, a mesophilic archaeal TopoIII,
was biochemically characterized in the context of well-established
properties of eukaryotic and bacterial type IA topoisomerases. We
demonstrate that MacTopoIIIa is a monomer in solution, binds
Zn
2+ and exhibits susceptibility to inhibitors in a manner similar to
other type IA topoisomerases. MacTopoIIIa is a distributive
topoisomerase that has a high affinity for ssDNA and is inhibited
by high salt concentrations. Properties that may be unique to this
enzyme are the ability of all divalent cations tested to elicit DNA
relaxation activity and the ability of this enzyme to bind Zn
2+ via
the N- and C-terminal. Further studies are needed in the domain
Archaea and beyond to determine if these attributes are domain or
organism specific.
Materials and Methods
Cloning and expression of M. acetivorans C2A TopoIIIa
(MacTopoIIIa) gene
The gene for the putative topoisomerase, MacTopoIIIa
(NP_617416), was amplified from the M. acetivorans C2A genomic
DNA using PCR primers containing restriction sites for NdeI and
XhoI in the forward (59-CATATGCACCTTATCGTAACG-
GAAAAAAATATA-39) and reverse (59-CTCGAGCTATAGG
TCCTCAACTATGCCGCCGTTACA-39) primers, respectively.
The size of the PCR product was verified through agarose gel
electrophoresis and cloned into pGEM-T, a TA-cloning vector
(Qiagen). The recombinant plasmid was purified using a Qiagen
gel extraction kit, and after confirming the integrity of the
sequence of the DNA insert, the MacTopoIIIa gene was
transferred into a modified pET28a expression vector. The
pET28a vector has its kanamycin resistance gene replaced with
an ampicillin resistance gene [52]. Therefore, the ligated products
were transformed into E. coli JM109 cells and transformants were
selected on lysogeny broth (LB) plates supplemented with
ampicillin at a final concentration of 100 mg/mL. The plates
were incubated overnight at 37uC, and a single colony was picked
and cultured in 10 mL LB containing the same antibiotic and
grown at 37uC for 8 hours. The plasmid was extracted from the E.
coli culture and examined for the presence of the MacTopoIIIa
gene through DNA sequencing. The recombinant plasmid was
named pET28a/MacTopoIIIa. All DNA sequencing in the
present report were carried out at the W. M. Keck Center for
Comparative and Functional Genomics (University of Illinois at
Urbana-Champaign).
The recombinant plasmid pET28/MacTopoIIIa was used in
transforming E. coli BL21 codonplus RIPL cells (Stratagene) and
plated on LB plates supplemented with ampicillin (100 mg/mL)
and chloramphenicol (50 mg/mL). A transformant was cultured at
37uC in 10 ml LB medium supplemented with both antibiotics at
the same concentrations stated above until the optical density
(O.D.) at 600 nm reached 0.3. The expression of the MacTo-
poIIIa gene was then induced by adding isopropyl b-D-
thiogalactopyranoside (IPTG) at a final concentration of 1 mM.
The temperature was decrease to 16uC and cell culturing was
continued for 12–16 hours. The recombinant E. coli cells were
then collected through centrifugation at 6500 rpm for 10 minutes.
Site-directed mutagenesis
Site-directed mutagenesis was carried out using the Quikchange
site-directed mutagenesis kit (Stratagene) according to the
instructions of the manufacturer. The PCR primer (59-AACGGG-
TATATATCTTTTCCCAGGACCGACAAT-39) was utilized to
convert MacTopoIIIa Tyr317 into Phe317. Mutagenized plasmid
was transformed into JM109 cells after digestion of the parental
plasmid with DpnI. The E. coli transformants were selected on LB
agar plates supplemented with ampicillin [100 mg/mL] overnight
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growth in liquid LB cultures supplemented with ampicillin
[100 mg/mL]. Plasmids were sequenced as described above, and
the desired plasmid containing the Y317F mutation was selected
for gene expression as described above for the wild-type gene.
Truncation mutagenesis
A truncated gene containing the DNA sequence for the N-
terminal 586 amino acids (N1-586) was generated using an
iProof
TM High-Fidelity PCR kit with a forward primer (59-
CATATGCACCTTATCGTAACGGAAAAAAATATA-39) and
reverse primer (59-CTCGAGCTATGCCTGCAGGGACTC-
TATGATTTTGTC-39) according to the manufacturer’s instruc-
tions. A truncated gene containing the DNA sequence for the C-
terminal 166 amino acids (C587–752) was generated in the same
manner with the forward primer (59-CATATGGGTCTCAGG-
GAAGACAAGATCATAGGCAAC-39) and the reverse primer
(59-CTCGAGCTATAGGTCCTCAACTATGCCGCCGTTACA-
39). The size of the PCR product was verified through agarose gel
electrophoresis and cloned into the pGEM-T vector (Qiagen).
Plasmids were transformed into JM109 cells after ligation. The E.
coli transformants were selected on LB agar plates supplemented
with ampicillin [100 mg/mL] overnight at 37uC. Plasmids were
extracted from individual colonies after growth in liquid cultures
supplemented with ampicillin [100 mg/mL]. Plasmids were se-
quenced as described above, and the correct inserts of N1-586 and
C587–752 were transferred to the modified pET28a for expression
as described above.
Purification of MacTopoIIIa and mutant proteins
For MacTopoIIIa wild-type protein and the Y317F mutant, the
harvested recombinant E. coli cells were resuspended in Buffer A
(50 mM Sodium phosphate, pH 7.0, 300 mM NaCl), and the cell
contents were released by a French pressure cell (American
Instruments Co). The cell debris was removed through centrifu-
gation at 9500 rpm for 15 min at 4uC. The supernatant was
subsequently filtered using a 0.22 mm filter and applied to a His-
Trap
TM HP column (GE Healthcare) pre-equilibrated with 90%
buffer A and 10% buffer B (50 mM Sodium phosphate, pH 7.0,
300 mM NaCl, 500 mM imidazole), and eluted using a step-wise
gradient of Buffer B.
Fractions containing the protein of interest were pooled and
dialyzed against buffer A (50 mM Sodium phosphate, pH 7.0,
300 mM NaCl) overnight at 4uC. Samples were applied to a
HiTrap
TM SP column (GE Healthcare) pre-equilibrated with
buffer A, and to elute the bound protein, a linear gradient using
100% buffer C (50 mM Sodium phosphate, pH 7.0, 1 M NaCl)
was utilized. Concentrated fractions of each protein were directly
applied to a size exclusion column (Superdex HR 200 HR 10/30
column) pre-equilibrated with buffer GF (50 mM sodium
phosphate, 150 mM sodium chloride, pH 7.0), and the chroma-
tography was developed with the same buffer. Highly purified
proteins were dialyzed against a storage buffer (50 mM Tris-HCl
pH 7.5, 200 mM NaCl, 2 mM DTT and 50% Glycerol) and
stored at 280uC until used.
In the case of MacTopoIIIa C587–752 truncated mutant, the
harvested recombinant E. coli cells were re-suspended in Buffer A,
and the cell contents were released by a French pressure cell
(American Instruments Co). The cell debris was removed through
centrifugation at 9500 rpm for 15 min at 4uC. The supernatant
was subsequently filtered using a 0.22 mm filter and applied to a
His-Trap
TM HP column (GE Healthcare) pre-equilibrated with
70% buffer A and 30% buffer B (50 mM Sodium phosphate,
pH 7.0, 300 mM NaCl, 500 mM imidazole), and eluted using a
linear gradient of buffer B.
The protein fractions from the HisTrap
TM HP column were
pooled and dialyzed against buffer A (50 mM Sodium phosphate,
pH 7.0, 300 mM NaCl) overnight at 4uC. Samples were applied
to a HiTrap
TM SP column (GE Healthcare) pre-equilibrated with
buffer A and eluted with a linear gradient of 100% buffer C.
Highly purified fractions were dialyzed against the storage buffer
and stored at 280uC until used.
In the case of MacTopoIIIa N1-586 truncated mutant, the
harvested recombinant E. coli cells were re-suspended in Buffer A,
and the cell contents were released by a French pressure cell
(American Instruments Co). The cell debris was removed through
centrifugation at 9500 rpm for 15 min at 4uC. The supernatant
was subsequently filtered using a 0.22 mm filter and applied to a
His-Trap
TM HP column (GE Healthcare) pre-equilibrated with
75% buffer A and 25% buffer B (50 mM Sodium phosphate,
pH 7.0, 300 mM NaCl, 500 mM imidazole), and eluted using a
linear gradient of buffer B.
The fractions of the MacTopoIIIa N1-586 truncated mutant
from the His-Trap column were pooled and dialyzed against
buffer A overnight at 4uC. Samples were then applied to a
HiTrap
TM heparin HP column (GE Healthcare) pre-equilibrated
with 90% buffer A and 10% buffer C. The MacTopoIIIa N1-586
truncated mutant was eluted with a step gradient using 75% buffer
A and 25% buffer C. Highly purified fractions were dialyzed
against the storage buffer and stored at 280uC until used. Aliquots
of eluted fractions from all chromatographies were examined
through SDS-PAGE.
Preparation of DNA substrates for topoisomerase assays
E. coli JM109 cells were heat shocked to uptake the pUC18
plasmid, and transformants were cultured in ampicillin supple-
mented (100 mg/mL) LB medium to amplify the plasmid. The
pUC18 plasmid was purified from cell pellets with a commercial
kit (Qiagen), and electrophoresed on a 1.5% agarose gel
containing 1X TBE (89 mM Tris, 89 mM Boric acid, 2 mM
EDTA). Subsequently, the gel was stained with ethidium bromide
and imaged with a UV illuminator. The plasmid DNA migrating
the fastest was excised and purified utilizing a gel extraction kit
(Qiagen) according to the manufacturer’s specifications. The
purified negatively supercoiled DNA was verified using a 2-
Dimensional gel with EcoRI linearized pUC18 and ethidium
bromide treated pUC18 as standards. The M13 ssDNA was from
a commercial source (New England Biolabs).
DNA relaxation assay
Unless otherwise stated, the method is the same as previously
described [22]. Briefly, reaction volumes contained 300 ng
negatively supercoiled pUC18 DNA in the presence of 5 pmol
of MacTopoIIIa wild-type (or its mutants) in 50 mM Tris-HCl,
pH 8.8, 1 mM DTT, 0.1 mM EDTA, 90 mM NaCl, 30 mgo f
BSA/ml, and 12% (vol/vol) ethylene glycol with the indicated
divalent cation. After 30 min incubation at 37uC (unless indicated
otherwise), reactions were terminated by adding 4 mL of DNA
loading dye (25% Glycerol, 0.2% Bromophenol Blue, 50 mM
EDTA) and the products were resolved with 1.5% agarose gel in
0.5X TPE (44.6 mM Tris, 0.13% Phosphoric acid, 1 mM EDTA)
buffer. DNA bands were visualized through ethidium bromide
staining and imaging with a UV illuminator.
The levels of negatively scDNA that remained or were relaxed
(partially and completely) were determined by densitometry using
AlphaEaseFC
TM software. For each divalent ion, the values for a
given lane were normalized to that obtained without any divalent
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according to the maximal percentage of substrate that was relaxed
(partially and completely) relative to the percentage of negatively
scDNA when no ion was present. High activity (Y) was utilized to
denote greater than or equal to 95% activity while medium
activity (M) denotes activity falling below 95%.
Determination of zinc content by ICP-MS
The zinc content in purified wild-type MacTopoIIIa and
variants was determined at the University of Illinois Microanalysis
Laboratory using the SCIEX ELAN DRCe ICP-MS (PerkinElmer
Life Sciences). Briefly, two aliquots of purified protein, 1 mL each,
at a concentration of approximately 0.5 mg/mL, were digested in
nitric acid. The resulting solutions were diluted to 25 mL and
analyzed. Two isotopes of zinc,
64Zn and
66Zn, were analyzed with
gallium as the internal standard.
Estimation of subunit organization by gel filtration
Since MacTopoIIIa was expressed with an N-terminal 6-His
tag, the protein eluted from the HiTrap
TM SP column was
incubated with the protease thrombin (1 unit/mg/mL) during
dialysis in buffer GF (50 mM sodium phosphate, 150 mM sodium
chloride, pH 7.0) in order to remove the tag. The dialyzate was
loaded onto a Superdex 200 HR 10/300 gel filtration column pre-
equilibrated with buffer GF. The chromatography was developed
with the same buffer at a flow rate of 0.5 ml/min and fractions of
0.5 ml were collected and analyzed by SDS-PAGE. To generate a
standard curve, the column was calibrated by analyzing a set of gel
filtration standards (thyroglobulin, 669 kDa; bovine c-globulin,
158 kDa; chicken ovalbumin, 44 kDa; equine myoglobin, 17 kDa;
and vitamin B12, 1.35 kDa) under the same conditions as the
MacTopoIIIa.
Materials
Methanosarcina acetivorans C2A genomic DNA was used for
amplification of the topoisomerase. E. coli JM109 competent cells
were used as host cells for amplification of the plasmids pGEM-T
and pUC18. The negatively supercoiled pGEM-T and pUC18
DNA were isolated with the Qiagen Mini Plasmid kit according to
the specification of the manufacturer and used in the topoisom-
erase assay as substrate DNA. Reagents for SDS–PAGE, 1 protein
molecular weight standards, 1 DNA molecular mass standards,
etoposide, camptothecin, EDTA, nalidixic acid, novobiocin,
spermidine, ethidium bromide and DTT were purchased from
Sigma. HiTrap Q HP, HiTrap S HP, and Superdex 200 HR 10/
30 columns were from GE Healthcare. BSA, single-stranded M13
ssDNA was from New England BioLabs. Gel Filtration standards
were obtained from Bio-Rad.
Supporting Information
Figure S1 Relaxation of negatively supercoiled pUC18
DNA by MacTopoIIIa N1-586 and C587–752 at higher
concentrations. Standard reaction mixtures with 90 mM NaCl
were incubated with 0.3 mg of pUC18 for 30 min at 37uC with
10 mM MgCl2. The only exception is Lane 1 which contains no
divalent cation. Lanes 1 and 2 contain 5 pmol of MacTopoIIIa
wild-type only. Lane 3 contains 50 pmol of N1-586 only. Lane 4
contains 50 pmol of C587–752 only. Lanes 5–11 contain varying
ratios of MacTopoIIIa C587–752 to MacTopoIIIa N1-586 in
pmol ranging from 50:1, to 50:5 to 50:10 to 50:50 to 10:50 to 5:50
to 1:50, respectively. Lanes 12–18 contain varying ratios of
MacTopoIIIa C587–752 to MacTopoIIIa N1-586 in pmol
ranging from 10:0.5, to 10:1 to 10:5 to 10:10 to 5:10 to 1:10 to
0.5:10, respectively.
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